IBDEI2S8 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44367,1,3,0)
 ;;=3^Inhalant Induced Maj Neurocog D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44367,1,4,0)
 ;;=4^F18.27
 ;;^UTILITY(U,$J,358.3,44367,2)
 ;;=^5003401
 ;;^UTILITY(U,$J,358.3,44368,0)
 ;;=F18.97^^164^2196^9
 ;;^UTILITY(U,$J,358.3,44368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44368,1,3,0)
 ;;=3^Inhalant Induced Maj Neurocog D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,44368,1,4,0)
 ;;=4^F18.97
 ;;^UTILITY(U,$J,358.3,44368,2)
 ;;=^5003413
 ;;^UTILITY(U,$J,358.3,44369,0)
 ;;=F18.188^^164^2196^10
 ;;^UTILITY(U,$J,358.3,44369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44369,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44369,1,4,0)
 ;;=4^F18.188
 ;;^UTILITY(U,$J,358.3,44369,2)
 ;;=^5003390
 ;;^UTILITY(U,$J,358.3,44370,0)
 ;;=F18.288^^164^2196^11
 ;;^UTILITY(U,$J,358.3,44370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44370,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44370,1,4,0)
 ;;=4^F18.288
 ;;^UTILITY(U,$J,358.3,44370,2)
 ;;=^5003403
 ;;^UTILITY(U,$J,358.3,44371,0)
 ;;=F18.988^^164^2196^12
 ;;^UTILITY(U,$J,358.3,44371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44371,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,44371,1,4,0)
 ;;=4^F18.988
 ;;^UTILITY(U,$J,358.3,44371,2)
 ;;=^5003415
 ;;^UTILITY(U,$J,358.3,44372,0)
 ;;=F18.159^^164^2196^13
 ;;^UTILITY(U,$J,358.3,44372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44372,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44372,1,4,0)
 ;;=4^F18.159
 ;;^UTILITY(U,$J,358.3,44372,2)
 ;;=^5003387
 ;;^UTILITY(U,$J,358.3,44373,0)
 ;;=F18.259^^164^2196^14
 ;;^UTILITY(U,$J,358.3,44373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44373,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44373,1,4,0)
 ;;=4^F18.259
 ;;^UTILITY(U,$J,358.3,44373,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,44374,0)
 ;;=F18.959^^164^2196^15
 ;;^UTILITY(U,$J,358.3,44374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44374,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,44374,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,44374,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,44375,0)
 ;;=F18.99^^164^2196^22
 ;;^UTILITY(U,$J,358.3,44375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44375,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,44375,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,44375,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,44376,0)
 ;;=F18.21^^164^2196^25
 ;;^UTILITY(U,$J,358.3,44376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44376,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,44376,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,44376,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,44377,0)
 ;;=F18.11^^164^2196^24
 ;;^UTILITY(U,$J,358.3,44377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44377,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,44377,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,44377,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,44378,0)
 ;;=Z00.6^^164^2197^1
 ;;^UTILITY(U,$J,358.3,44378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44378,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,44378,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,44378,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,44379,0)
 ;;=F45.8^^164^2198^13
